Gail M Folena-Wasserman insider trades: Medimmune (MEDI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gail reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 14, 2005 | MEDI | ↓ Sell | 42,000 | $35.36 | $1.5M | Direct | Nov 16, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gail M Folena-Wasserman's insider trades
Gail M Folena-Wasserman is SVP, Development at Medimmune (MEDI). Since Nov 14, 2005, Gail has reported no open-market purchases and 1 sale worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEDI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.